Twist Bioscience makes high-quality synthetic DNA using its proprietary silicon platform. In 2019, Twist launched a long oligonucleotide (oligos) product line, setting a new commercial industry record of up to 300 bases. By assembling oligos together into longer fragments that encode synthetic genes, engineers can instruct bacteria or yeast cells to make a wider range of proteins with more accuracy.